Top Articles

At present, the Covid-19 pandemic is the focus of the global community and an all-consuming threat to the health care systems all across Europe. Resources and medical staff are reallocated, and planned medical activities are delayed or cancelled. Covid-19 poses… Continue Reading

06. April 2020 Coronavirus Disease 2019 (COVID-19) typically causes fever, pulmonary and respiratory symptoms as well as gastrointestinal symptoms in the form of diarrhoea. The disease may develop as pneumonia and acute respiratory distress syndrome, which may cause death. Neurological… Continue Reading

Released on April 3rd, 2020 To our knowledge, there is currently no evidence on how and if Corona Virus Disease 2019 (COVID-19) affects people with rare neurological diseases, mainly neurogenetics (NGDs). A recent (April 3rd) research on PubMed did not… Continue Reading

We are experiencing an unprecedented situation that no one had imagined or prepared for which has hit Europe during a period of prosperity, and the whole world. COVID-19 has come as a shock. In this context, headache services have to… Continue Reading

The new Corona virus disease 2019 (COVID-19) has drastically changed the world as we know it. Every aspect of our lives has been modified to adapt ourselves and to prevent the spread of this novel coronavirus (SARS-CoV-2). According to the World Health Organization (WHO), 1 279 722 confirmed cases have been reported worldwide with more than 72 616 deaths (as of 7 April 2020). Africa is the least affected region (10,260 confirmed cases and 492 deaths). However, this number may be underestimated and is continuing to rise relentlessly. Thus, Africa is facing the biggest challenge of the 21st century: making health as a priority. Scientific societies, national and international health authorities have to work together to strengthen the fight against SARS-CoV-2 and COVID-19.

Neuromuscular patients management in the COVID era Neuromuscular diseases are a group of heterogenic rare conditions, that can be due to a genetic cause, inflammatory processes or dysimmune disorders. Pathogenic processes can affect motor neurons, peripheral nerves, neuromuscular junction, or… Continue Reading

Due to the CoVID-19 pandemic spread, most outpatient facilities have been strictly regulated, thus making it difficult for many patients suffering from chronic pain to access treatment. During this tough period, all pain physicians, including neurologists, are working to find… Continue Reading

The Covid-19 global pandemic is having a dramatic impact on many chronic conditions including those affecting neurological patients and among them those with movement disorders. In many cases, to protect vulnerable movement disorders patients from becoming infected, appointments have been… Continue Reading

Specific challenges at present regarding Covid-19 and how these are being addressed
Highly pathogenic coronavirus infections are well-established sources of previous epidemics (severe acute respiratory syndrome coronavirus: SARS‐CoV, Middle East respiratory syndrome coronavirus: MERS‐CoV). Of interest, the novel coronavirus named… Continue Reading

Online registration for the EAN Virtual Congress 2020 (May 23-26) is now OPEN!

We are excited to announce that we have improved our online community platform, MyEAN!

Since January 31st, Coronavirus has spread along all the Spanish territory; however, some regions are particularly compromised in terms of number of cases: Madrid, Catalonia, Basque Country and the two Castillian regions. The total number of confirmed cases is about to surpass Italy. We hope to be reaching the plateau of the curve, after all the implemented social distancing measures.

The European Reference Netowrk for Epilepsy (EpiCARE) will hold a special webinar on Tuesday, April 7 with experts from Spain and Italy on the change to epilepsy care due to the COVID-19 pandemic.

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus causes a pneumonia syndrome, with specific and already well-described symptoms, and fatal outcome in a subset of patients. The lungs are… Continue Reading

Tim J von Oertzen, Ronan McGinty, Martin Holtkamp, Reetta Kalviainen, Stephan Ruegg, Eugen Trinka, Guido Rubboli 3rd April 2020 Physicians of all specialties worldwide are challenged by the new SARS-CoV-2 virus causing corona virus disease 2019 (COVID-19). The virus is… Continue Reading